Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association between serum ferritin level and fibromyalgia syndrome

European Journal of Clinical Nutrition volume 64, pages 308–312 (2010)Cite this article

Subjects

Abstract

Background/Objectives:

Iron is essential for a number of enzymes involved in neurotransmitter synthesis. Analysis of cerebrospinal fluid in fibromyalgia syndrome (FMS) has shown a reduction in the concentration of biogenic amine metabolites, including dopamine, norepinephrine and serotonin. This study aimed to investigate the association of ferritin with FMS.

Subjects/Methods:

A total of 46 patients with primary FMS participated in this case–control study, and 46 healthy females who were age matched to the patients were used as the control group. Venous blood samples collected from all subjects were used to evaluate serum ferritin, vitamin B12 and folic acid levels.

Results:

The mean serum ferritin levels in the fibromyalgia (FM) and control groups were 27.3±20.9 and 43.8±30.8 ng/ml, respectively, and the difference was statistically significant (P=0.003). Binary multiple logistic regression analysis with age, body mass index, smoking status and vitamin B12, as well as folic acid and ferritin levels showed that having a serum ferritin level <50 ng/ml caused a 6.5-fold increased risk for FMS.

Conclusions:

Our study implicates a possible association between FM and decreased ferritin level, even for ferritin in normal ranges. We suggest that iron as a cofactor in serotonin and dopamine production may have a role in the etiology of FMS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Abeles AM, Pillinger MH, Solitar BM, Abeles M (2007). Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 146, 726–734.

    Article  PubMed  Google Scholar 

  • Allen R (2004). Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 5, 385–391.

    Article  PubMed  Google Scholar 

  • Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003). Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4, 101–119.

    Article  PubMed  Google Scholar 

  • Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P et al. (2006). Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8, R99.

    Article  PubMed  PubMed Central  Google Scholar 

  • Beard JL, Connor JR, Jones BC (1993). Iron in the brain. Nutr Rev 51, 157–170.

    Article  CAS  PubMed  Google Scholar 

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4, 561–571.

    Article  CAS  PubMed  Google Scholar 

  • Burckhardt CS, Clark SR, Bennett RM (1991). The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18, 728–733.

    CAS  PubMed  Google Scholar 

  • DeMaeyer E, Adiels-Tegman M (1985). The prevalence of anaemia in the world. World Health Stat Q 38, 302–316.

    CAS  PubMed  Google Scholar 

  • Dowling P, Klinker F, Amaya F, Paulus W, Liebetanz D (2009). Iron-deficiency sensitizes mice to acute pain stimuli and formalin-induced nociception. J Nutr 139, 2087–2092.

    Article  CAS  PubMed  Google Scholar 

  • Gamaldo CE, Earley CJ (2006). Restless legs syndrome: a clinical update. Chest 130, 1596–1604.

    Article  PubMed  Google Scholar 

  • Gerwin R (2005). A review of myofascial pain and fibromyalgia––factors that promote their persistence. Acupunct Med 23, 121–134.

    Article  PubMed  Google Scholar 

  • Hisli N (1988). The reliability and validity study of the Beck Depression Inventory in a Turkish sample. Turk J Psychol(in Turkish) 6, 118–122.

    Google Scholar 

  • Kathlen ML, Escott-Stump S (2004). Krauses Food Nutrition and Diet Therapy, 10th edn Chapman and Hall: Philadelphia, PA.

    Google Scholar 

  • Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrou M, Alvado G et al. (2001). Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford) 40, 290–296.

    Article  CAS  Google Scholar 

  • Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J (2005). CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 14, 43–47.

    Article  PubMed  Google Scholar 

  • Moldofsky H, Warsh JJ (1978). Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (‘fibrositis syndrome’). Pain 5, 65–71.

    Article  CAS  PubMed  Google Scholar 

  • Morse AC, Beard JL, Jones BC (1999). A genetic developmental model of iron deficiency: biological aspects. Proc Soc Exp Biol Med 220, 147–152.

    Article  CAS  PubMed  Google Scholar 

  • Neeck G (2002). Pathogenic mechanisms of fibromyalgia. Ageing Res Rev 1, 243–255.

    Article  CAS  PubMed  Google Scholar 

  • O’Keeffe ST, Gavin K, Lavan JN (1994). Iron status and restless legs syndrome in the elderly. Age Ageing 23, 200–203.

    Article  PubMed  Google Scholar 

  • Otto M, Bach FW, Jensen TS, Brosen K, Sindrup SH (2008). Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial. Pain 139, 275–283.

    Article  CAS  PubMed  Google Scholar 

  • Pamuk GE, Pamuk ON, Set T, Harmandar O, Yesil N (2008). An increased prevalence of fibromyalgia in iron deficiency anemia and thalassemia minor and associated factors. Clin Rheumatol 27, 1103–1108.

    Article  PubMed  Google Scholar 

  • Russell IJ, Vaeroy H, Javors M, Nyberg F (1992). Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35, 550–556.

    Article  CAS  PubMed  Google Scholar 

  • Sarmer S, Ergin S, Yavuzer G (2000). The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20, 9–12.

    Article  CAS  PubMed  Google Scholar 

  • Sun ER, Chen CA, Ho G, Earley CJ, Allen RP (1998). Iron and the restless legs syndrome. Sleep 21, 371–377.

    Article  CAS  PubMed  Google Scholar 

  • Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M, Shahbaazi SH, Abadi A (2007). The relationship between depression and serum ferritin level. Eur J Clin Nutr 61, 532–535.

    Article  CAS  PubMed  Google Scholar 

  • Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33, 160–172.

    Article  CAS  PubMed  Google Scholar 

  • Wood PB, Patterson II JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL (2007a). Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8, 51–58.

    Article  CAS  PubMed  Google Scholar 

  • Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA et al. (2007b). Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25, 3576–3582.

    Article  PubMed  Google Scholar 

  • Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 19, 90–94.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was approved by the Hospital Ethics Committee of Zonguldak Karaelmas University.

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak, Turkey

    O Ortancil, A Sanli & A Basaran

  2. Department of Physical Medicine and Rehabilitation, Ministry of Health Zonguldak State Hospital, Zonguldak, Turkey

    R Eryuksel

  3. Department of Biostatistics, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak, Turkey

    H Ankarali

Authors
  1. O Ortancil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Sanli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Eryuksel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Basaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Ankarali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O Ortancil.

Additional information

This article was presented as a poster (P-051) in National Rheumatic Diseases Congress, 14–18 May 2008, Antalya, Turkey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ortancil, O., Sanli, A., Eryuksel, R. et al. Association between serum ferritin level and fibromyalgia syndrome. Eur J Clin Nutr 64, 308–312 (2010). https://doi.org/10.1038/ejcn.2009.149

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2009.149

Keywords

This article is cited by

Search

Advanced search

Quick links